The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Implications of ethnicity among patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab plus ipilimumab (nivo/ipi).
 
Sally Leong
No Relationships to Disclose
 
Sana Ali
No Relationships to Disclose
 
Zeynep Busra Zengin
No Relationships to Disclose
 
Luis A Meza
No Relationships to Disclose
 
Nazli Dizman
Consulting or Advisory Role - Vivreon Biosciences
 
Hedyeh Ebrahimi
No Relationships to Disclose
 
Ameish Govindarajan
No Relationships to Disclose
 
Daniela V. Castro
No Relationships to Disclose
 
Xiaochen Li
No Relationships to Disclose
 
Tane Kim
No Relationships to Disclose
 
Sam Melamed
Employment - University of California Los Angeles
 
Mykola Onyshchenko
Consulting or Advisory Role - Bayer; Blueprint Medicines; Sanofi/Regeneron
Speakers' Bureau - Natera
 
Sumanta Monty Pal
Research Funding - Allogene Therapeutics (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - crispr therapeutics; Roche
 
Alex Chehrazi-Raffle
No Relationships to Disclose